Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Antiinflammatory drug salsalate studied for type 2 diabetes

Jan. 19, 2007

Swiss clearance for phase II anemia study of NE-180 in cancer patients

Jan. 19, 2007

Phenoptin causes significant increase in phenylalanine tolerance in PKU

Jan. 18, 2007

MER-103 data indicate improved convenience, compliance for alendronate therapy

Jan. 18, 2007

Phase II trial of VT-122 for cachexia cleared to begin

Jan. 18, 2007

Novel agents for treating endocrine-related disorders disclosed in recent patents

Jan. 17, 2007

BMS-201038 effective in familial hypercholesterolemia

Jan. 17, 2007

Novo Nordisk focuses R&D on therapeutic proteins

Jan. 17, 2007

Somatuline Autogel NDA accepted for filing

Jan. 16, 2007

CytRx establishes new RNAi subsidiary, RXi Pharmaceuticals

Jan. 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...